Dalian BIO-CHEM Past Earnings Performance
Past criteria checks 2/6
Dalian BIO-CHEM has been growing earnings at an average annual rate of 5.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 8.3% per year. Dalian BIO-CHEM's return on equity is 17.7%, and it has net margins of 27%.
Key information
5.7%
Earnings growth rate
6.7%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 8.3% |
| Return on equity | 17.7% |
| Net Margin | 27.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dalian BIO-CHEM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,110 | 300 | 120 | 46 |
| 30 Jun 24 | 1,076 | 303 | 118 | 42 |
| 31 Mar 24 | 1,146 | 354 | 120 | 41 |
| 31 Dec 23 | 1,066 | 328 | 119 | 39 |
| 30 Sep 23 | 1,104 | 349 | 127 | 35 |
| 30 Jun 23 | 1,169 | 365 | 141 | 34 |
| 31 Mar 23 | 1,220 | 377 | 123 | 40 |
| 31 Dec 22 | 1,257 | 403 | 133 | 47 |
| 30 Sep 22 | 1,318 | 426 | 115 | 57 |
| 30 Jun 22 | 1,192 | 355 | 120 | 57 |
| 31 Mar 22 | 1,082 | 297 | 111 | 49 |
| 31 Dec 21 | 1,006 | 250 | 96 | 40 |
| 30 Sep 21 | 875 | 203 | 85 | 34 |
| 30 Jun 21 | 827 | 217 | 79 | 33 |
| 31 Mar 21 | 768 | 184 | 111 | 33 |
| 31 Dec 20 | 750 | 222 | 108 | 29 |
| 30 Sep 20 | 837 | 251 | 154 | 31 |
| 30 Jun 20 | 920 | 322 | 150 | 31 |
| 31 Mar 20 | 934 | 365 | 121 | 28 |
| 31 Dec 19 | 872 | 307 | 116 | 28 |
| 30 Sep 19 | 727 | 271 | 80 | 26 |
| 30 Jun 19 | 626 | 195 | 77 | 24 |
| 31 Mar 19 | 539 | 150 | 69 | 19 |
| 31 Dec 18 | 528 | 145 | 61 | 19 |
| 30 Sep 18 | 517 | 127 | 52 | 25 |
| 30 Jun 18 | 471 | 109 | 50 | 18 |
| 31 Mar 18 | 440 | 100 | 53 | 17 |
| 31 Dec 17 | 410 | 100 | 55 | 15 |
| 30 Sep 17 | 392 | 107 | 71 | 0 |
| 30 Jun 17 | 393 | 109 | 70 | 0 |
| 31 Mar 17 | 402 | 107 | 70 | 0 |
| 31 Dec 16 | 389 | 98 | 67 | 0 |
| 30 Sep 16 | 365 | 82 | 65 | 0 |
| 31 Dec 15 | 328 | 57 | 55 | 0 |
| 31 Dec 14 | 347 | 64 | 51 | 0 |
| 31 Dec 13 | 291 | 49 | 50 | 0 |
Quality Earnings: 603360 has high quality earnings.
Growing Profit Margin: 603360's current net profit margins (27%) are lower than last year (31.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603360's earnings have grown by 5.7% per year over the past 5 years.
Accelerating Growth: 603360's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 603360 had negative earnings growth (-14.3%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 603360's Return on Equity (17.7%) is considered low.